Arphra/Issuer/UTHR

UTHR

United Therapeutics Corporation

HealthcareBiotechnologyUSUSD

$540.05

LiveJun 02, 2026

AI Brief

Market cap

$22.92B

52w range

272.12 – 609.35

P / E

—

EPS

—

Volume

370.57K

Revenue · FY

—

Explain this page

Arphra AIPlain-English read on United Therapeutics Corporation’s valuation

AI Issuer Brief

Arphra AI

Loading cached brief…

Insider · 30d

Bought

0 txns

Sold

$2.47M

10 txns

Net flow

−$2.47M

Full history →

Price

DB · prices_daily

1M 6M 1Y 5Y

No price history in prices_daily for UTHR.

Peers

No peer list available for UTHR.

Price change · trailing returns

Live

1D	5D	1M	3M	6M	YTD	1Y	3Y	5Y	10Y	Max
-0.84%	-4.08%	-5.32%	+8.30%	+12.29%	+10.84%	+66.58%	+146.73%	+208.18%	+364.32%	+8762.36%

Aftermarket

Live

Jun 02, 10:27 PM

Last trade

$540.05

66 sh

Bid

$523.00

2 sh

Ask

$555.00

200 sh

Spread

$32.000

Sector & industry today

Live

Sectors

Technology
+1.59%
Industrials
+1.50%
Energy
+1.40%
Basic Materials
+1.36%
Utilities
+0.94%
Consumer Cyclical
+0.45%
Real Estate
+0.37%
Consumer Defensive
+0.28%
Financial Services
+0.05%
Healthcare
-0.26%
Communication Services
-0.39%

Top industries (issuer's industry highlighted)

Biotechnology
-1.42%
Hardware, Equipment & Parts
+5.17%
Computer Hardware
-4.64%
REIT - Office
+4.28%
Communication Equipment
+4.02%
Electronic Gaming & Multimedia
-3.94%
Real Estate - Services
+3.82%
Agricultural - Machinery
+3.64%
Auto - Parts
+3.58%
Oil & Gas Energy
+3.45%
Information Technology Services
+3.19%
Copper
+3.00%

Fair value

Football field →

Weighted blend

—

— vs spot

Recommendation

n/a

0 of 0 methods

Method spread

0bull0bear

±5% threshold

Analyst PT consensus: $636.83 (+17.92%)

Total assets

—

Total debt

—

Cash & equiv

—

Operating CF

—

Free cash flow

—

Buybacks

—

Analyst view

Consensus target

—

No price-target data returned for this ticker.

Recent actions

0 ↑0 ↓0 hold

No recent grade actions.

News

DB · news_items

Recent quarters

All financials →

Period	Revenue	Net income	EPS

Recent insiders

All →

Insider	Action	Shares	Value	Date
ROTHBLATT MARTINE A director, officer: Chairperson & CEO	Sell	56	$32.67K	May 12, 2026
ROTHBLATT MARTINE A director, officer: Chairperson & CEO	Sell	106	$60.6K	May 12, 2026
ROTHBLATT MARTINE A director, officer: Chairperson & CEO	Sell	240	$136.52K	May 12, 2026
ROTHBLATT MARTINE A director, officer: Chairperson & CEO	Sell	293	$167.92K	May 12, 2026
ROTHBLATT MARTINE A director, officer: Chairperson & CEO	Sell	400	$228.13K	May 12, 2026
ROTHBLATT MARTINE A director, officer: Chairperson & CEO	Sell	401	$230.05K	May 12, 2026

Income statement · annual

Open Financials →

Period	Revenue	Op income	Net income	EPS	Net margin